Physician profile
Aparna Kumar
NPI 1518194109
$983.99
in general payments reported to CMS, 2019-2025
20 companies · $78.99 in 2025
The $78.99 reported for 2025 was less than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $620 · 2020: $265 · 2023: $19.17 · 2025: $78.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $78.99 · Food and Beverage: $19.17.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $78.99 |
| Food and Beverage | $19.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $174.73 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $94.49 | 2019 | |
| Philips North America LLC | $94.31 | 2019-2020 | |
| Glaxosmithkline, LLC. | $90.43 | 2019-2020 | |
| Mylan Specialty L.P. | $85.43 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $78.99 | 2025 | |
| Genzyme Corporation | $62.09 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $45.50 | 2019-2020 | |
| Insmed, INC. | $42.55 | 2019 | |
| Ethicon INC. | $34.06 | 2020 | |
| Karl Storz Endoscopy-America | $26.89 | 2019 | |
| Astellas Pharma US INC | $24.43 | 2020 | |
| Fortovia Therapeutics, INC. | $21.02 | 2019 | |
| United Therapeutics Corporation | $19.17 | 2023 | Tyvaso |
| Allergan, INC. | $18.77 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $16.40 | 2020 | |
| Shire North American Group INC | $15.11 | 2019 | |
| Grifols USA, LLC | $14.77 | 2019 | |
| Mallinckrodt Enterprises LLC | $12.96 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aparna Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.